Abstract
Lipid emulsions in parenteral nutrition are commonly associated with fungal infections, and this assumption may cause parenteral nutrition administration to be discontinued in patients who are benefiting from it. Our purpose was to describe the multiple factors associated to fungemia in patients with parenteral nutrition and to describe the management of this condition. So, it is of utmost importance to review current information in order to be able to either recommend or suspend lipid emulsion in patients with infection risk. The theory that lipid emulsions in parenteral nutrition are associated with fungal infections is weak and other factors need to be considered when suggesting recommendations for the duration of parenteral nutrition or lipid emulsion administration. We review current information about fungemia in parenteral nutrition. We review epidemiology, etiology, risk factors associated with fungemia, and topics of interest such as the relationship between lipids in parenteral nutrition and infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
